Combination therapy of niclosamide with gemcitabine inhibited cell proliferation and apoptosis via Wnt/β-catenin/c-Myc signaling pathway by inducing β-catenin ubiquitination in pancreatic cancer
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Combination therapy of niclosamide with gemcitabine inhibited cell proliferation and apoptosis via Wnt/β-catenin/c-Myc signaling pathway by inducing β-catenin ubiquitination in pancreatic cancer
Authors
Keywords
-
Journal
CANCER BIOLOGY & THERAPY
Volume 24, Issue 1, Pages -
Publisher
Informa UK Limited
Online
2023-11-03
DOI
10.1080/15384047.2023.2272334
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical CDK4/6 inhibitors induce selective and immediate dissociation of p21 from cyclin D-CDK4 to inhibit CDK2
- (2021) Lindsey R. Pack et al. Nature Communications
- Repurposing Niclosamide for Targeting Pancreatic Cancer by Inhibiting Hh/Gli Non-Canonical Axis of Gsk3β
- (2021) Jyoti B. Kaushal et al. Cancers
- Wnt signaling in cancer: therapeutic targeting of Wnt signaling beyond β-catenin and the destruction complex
- (2020) Youn-Sang Jung et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- New Treatment Strategies for Metastatic Pancreatic Ductal Adenocarcinoma
- (2020) Ritu Raj Singh et al. DRUGS
- Pancreatic cancer
- (2020) Jonathan D Mizrahi et al. LANCET
- ABL1-dependent OTULIN phosphorylation promotes genotoxic Wnt/β-catenin activation to enhance drug resistance in breast cancers
- (2020) Wei Wang et al. Nature Communications
- Niclosamide-induced Wnt signaling inhibition in colorectal cancer is mediated by autophagy
- (2019) Jiangbo Wang et al. BIOCHEMICAL JOURNAL
- Niclosamide Induces Cell Cycle Arrest in G1 Phase in Head and Neck Squamous Cell Carcinoma Through Let-7d/CDC34 Axis
- (2019) Zewen Han et al. Frontiers in Pharmacology
- Chemoresistance in Pancreatic Cancer
- (2019) Zeng et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Niclosamide: Beyond an antihelminthic drug
- (2018) Wei Chen et al. CELLULAR SIGNALLING
- YAP-dependent ubiquitination and degradation of β-catenin mediates inhibition of Wnt signalling induced by Physalin F in colorectal cancer
- (2018) Chen Chen et al. Cell Death & Disease
- Natural compound Oblongifolin C confers gemcitabine resistance in pancreatic cancer by downregulating Src/MAPK/ERK pathways
- (2018) Yang Li et al. Cell Death & Disease
- Identification of novel triazole inhibitors of Wnt/β-catenin signaling based on the Niclosamide chemotype
- (2018) Robert A. Mook et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Niclosamide induces protein ubiquitination and inhibits multiple pro-survival signaling pathways in the human glioblastoma U-87 MG cell line
- (2017) Benxu Cheng et al. PLoS One
- Improved survival after palliative resection of unsuspected stage IV pancreatic ductal adenocarcinoma
- (2016) Younghwan Kim et al. HPB
- Niclosamide inhibits the proliferation of human osteosarcoma cell lines by inducing apoptosis and cell cycle arrest
- (2015) ZONGHUAN LI et al. ONCOLOGY REPORTS
- Multi-targeted therapy of cancer by niclosamide: A new application for an old drug
- (2014) Yonghe Li et al. CANCER LETTERS
- Regulation of Wnt/β-catenin signaling by posttranslational modifications
- (2014) Chenxi Gao et al. Cell and Bioscience
- Niclosamide Overcomes Acquired Resistance to Erlotinib through Suppression of STAT3 in Non-Small Cell Lung Cancer
- (2013) R. Li et al. MOLECULAR CANCER THERAPEUTICS
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of STAT3 by Niclosamide Synergizes with Erlotinib against Head and Neck Cancer
- (2013) Rui Li et al. PLoS One
- The -Catenin Destruction Complex
- (2012) J. L. Stamos et al. Cold Spring Harbor Perspectives in Biology
- Niclosamide induces mitochondria fragmentation and promotes both apoptotic and autophagic cell death
- (2011) So-Jung Park et al. BMB Reports
- Antihelminth Compound Niclosamide Downregulates Wnt Signaling and Elicits Antitumor Responses in Tumors with Activating APC Mutations
- (2011) T. Osada et al. CANCER RESEARCH
- Niclosamide Suppresses Cancer Cell Growth By Inducing Wnt Co-Receptor LRP6 Degradation and Inhibiting the Wnt/β-Catenin Pathway
- (2011) Wenyan Lu et al. PLoS One
- Identification of Niclosamide as a New Small-Molecule Inhibitor of the STAT3 Signaling Pathway
- (2010) Xiaomei Ren et al. ACS Medicinal Chemistry Letters
- The Anti-Helminthic Niclosamide Inhibits Wnt/Frizzled1 Signaling
- (2009) Minyong Chen et al. BIOCHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search